3563 related articles for article (PubMed ID: 26029972)
21. Antidepressant treatment for postnatal depression.
Molyneaux E; Howard LM; McGeown HR; Karia AM; Trevillion K
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002018. PubMed ID: 25211400
[TBL] [Abstract][Full Text] [Related]
22. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
[TBL] [Abstract][Full Text] [Related]
23. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.
Agabio R; Trogu E; Pani PP
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008581. PubMed ID: 29688573
[TBL] [Abstract][Full Text] [Related]
24. Antidepressant treatment for postnatal depression.
Brown JVE; Wilson CA; Ayre K; Robertson L; South E; Molyneaux E; Trevillion K; Howard LM; Khalifeh H
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013560. PubMed ID: 33580709
[TBL] [Abstract][Full Text] [Related]
25. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
26. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
27. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults.
Imai H; Tajika A; Chen P; Pompoli A; Furukawa TA
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011170. PubMed ID: 27730622
[TBL] [Abstract][Full Text] [Related]
28. Antidepressants and benzodiazepines for panic disorder in adults.
Bighelli I; Trespidi C; Castellazzi M; Cipriani A; Furukawa TA; Girlanda F; Guaiana G; Koesters M; Barbui C
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD011567. PubMed ID: 27618521
[TBL] [Abstract][Full Text] [Related]
29. Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises.
Purgato M; Gastaldon C; Papola D; van Ommeren M; Barbui C; Tol WA
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011849. PubMed ID: 29975811
[TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological interventions for people with borderline personality disorder.
Stoffers-Winterling JM; Storebø OJ; Pereira Ribeiro J; Kongerslev MT; Völlm BA; Mattivi JT; Faltinsen E; Todorovac A; Jørgensen MS; Callesen HE; Sales CP; Schaug JP; Simonsen E; Lieb K
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD012956. PubMed ID: 36375174
[TBL] [Abstract][Full Text] [Related]
32. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
[TBL] [Abstract][Full Text] [Related]
33. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Mead GE; Hsieh CF; Lee R; Kutlubaev MA; Claxton A; Hankey GJ; Hackett ML
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD009286. PubMed ID: 23152272
[TBL] [Abstract][Full Text] [Related]
34. Ketamine and other glutamate receptor modulators for depression in adults.
Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
[TBL] [Abstract][Full Text] [Related]
35. Omega-3 fatty acids for depression in adults.
Appleton KM; Voyias PD; Sallis HM; Dawson S; Ness AR; Churchill R; Perry R
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004692. PubMed ID: 34817851
[TBL] [Abstract][Full Text] [Related]
36. Milnacipran versus other antidepressive agents for depression.
Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD006529. PubMed ID: 19588396
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological interventions for treatment-resistant depression in adults.
Davies P; Ijaz S; Williams CJ; Kessler D; Lewis G; Wiles N
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010557. PubMed ID: 31846068
[TBL] [Abstract][Full Text] [Related]
38. Fluoxetine versus other types of pharmacotherapy for depression.
Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological treatment for psychotic depression.
Kruizinga J; Liemburg E; Burger H; Cipriani A; Geddes J; Robertson L; Vogelaar B; Nolen WA
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD004044. PubMed ID: 34875106
[TBL] [Abstract][Full Text] [Related]
40. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
